Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$515K Buy
6,500
+532
+9% +$42.3K 0.18% 132
2025
Q1
$536K Sell
5,968
-350
-6% -$32.7K 0.19% 119
2024
Q4
$628K Sell
6,318
-294
-4% -$30.3K 0.23% 105
2024
Q3
$751K Buy
6,612
+424
+7% +$50.4K 0.27% 98
2024
Q2
$766K Buy
6,188
+200
+3% +$25.8K 0.3% 83
2024
Q1
$790K Buy
5,988
+216
+4% +$26.6K 0.31% 88
2023
Q4
$629K Buy
5,772
+265
+5% +$27.5K 0.26% 104
2023
Q3
$567K Buy
5,507
+1,070
+24% +$115K 0.27% 103
2023
Q2
$512K Buy
4,437
+515
+13% +$58.5K 0.23% 110
2023
Q1
$417K Buy
3,922
+971
+33% +$105K 0.2% 120
2022
Q4
$327K Buy
+2,951
New +$302K 0.17% 134
2020
Q1
Sell
-1,374
Closed -$119K 335
2019
Q4
$119K Buy
+1,374
New +$113K 0.07% 211

Other funds holding MRK

TFG Advisers's MRK Position: Q2 2025 in Review

TFG Advisers increased its Merck (MRK) stake by 8.9% in Q2 2025, buying an estimated $42.3K and bringing the position to 6,500 shares worth $515K. The position accounts for 0.18% of the portfolio, ranked #132.

TFG Advisers first reported a position in MRK in Q4 2019 and has held it in 12 quarters since. The position peaked at $790K in Q1 2024. 3,327 funds tracked by Wall St. Rank hold MRK as of Q2 2025.

  • TFG Advisers held 6,500 shares of Merck worth $515K as of Q2 2025.
  • TFG Advisers bought 532 Merck shares in Q2 2025, an estimated $42.3K.
  • Merck made up 0.18% of TFG Advisers's portfolio in Q2 2025, its #132 holding.
  • TFG Advisers first reported a position in Merck in Q4 2019 and has held it in 12 quarters since.
  • TFG Advisers's Merck position peaked at $790K in Q1 2024.
  • 3,327 funds tracked by Wall St. Rank held Merck as of Q2 2025.

Based on TFG Advisers's 13F filing for Q2 2025, filed 21 Jul 2025.